-
GLP-1 receptor agonist lixisenatide may help slow the progression of Parkinson’s symptoms
Medical Mythbusting Commentary for April 10, 2024 Source:Ozempic-like drug may help slow the progression of Parkinson’s symptoms Reference:Trial of Lixisenatide in Early Parkinson’s Disease
-
New non-invasive tool can detect early stages of Alzheimer’s and Parkinson’s. However device is in prototype stage with further testing and evaluation to follow.
Medical Mythbusting Commentary for June 5, 2023 Source:New non-invasive tool can detect early stages of Alzheimer’s and Parkinson’s
-
Misleading headline misrepresents risk when it implies airborne trichloroethylene exposure is linked to increasing risk of developing Parkinson’s when the study was based on water supply contamination at Camp Lejeune.
Medical Mythbusting Commentary for May 18, 2023 Source:Chemical detected in the air inside Canadian homes linked to increase in developing Parkinson’s disease, says new report Reference:Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune
-
Michael J. Fox opens up about Parkinson’s progression: ‘I won’t be 80’
Medical Mythbusting Commentary for May 2, 2023 Source:Michael J. Fox opens up about Parkinson’s progression: ‘I won’t be 80’
-
Harry Forestell, host of CBC News New Brunswick at Six provides his first person account of his brain surgery for Parkinson’s.
Medical Mythbusting Commentary for February 21, 2023 Source:I was wide awake during my brain surgery for Parkinson’s. Here’s how it changed my life
-
Scientists from Johns Hopkins University have genetically engineered an experimental nanobody that targets alpha-synuclein protein clumps thought to be involved in the pathophysiology of Parkinson’s disease
Medical Mythbusting Commentary for August 9, 2022 Source:Parkinson’s research: Experimental nanobody targets toxic proteins Reference:α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
-
Blood test for Parkinson’s in early stage but represents good science
Health Headlines Commentary for February 9, 2017 Source: Blood test might make Parkinson’s diagnosis easier, study says Simple blood test may be accurate in differentiating between Parkinson’s disease and APDs Reference: Blood-based NfL A biomarker for differential diagnosis of parkinsonian disorder
-
Small study leading to larger trials for cancer drug that reverses Parkinson’s symptoms
Madely Health Headlines Commentary for October 19, 2015 Source: Cancer drug shows promise for reversing symptoms of Parkinson’s disease
-
Rat model shows promise for stem cell treatment for Parkinson's disease
Madely Health Headlines Commentary for November 7, 2014 Source: Breakthrough in stem cell treatment for Parkinson’s Reference: Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson’s Disease, Shane Grealish, et al., Cell Stem Cell, doi:10.1016/j.stem.2014.09.017, published online 6 November 2014,abstract.